CPBTD
XBI icon

Central Pacific Bank - Trust Division’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Central Pacific Bank - Trust Division’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.75K Buy
30
+3
+11% +$406 ﹤0.01% 749
2026
Q1 		$3.45K Hold
27
– – ﹤0.01% 753
2025
Q4 		$3.29K Buy
27
+11
+69% +$1.26K ﹤0.01% 747
2025
Q3 		$1.6K Hold
16
– – ﹤0.01% 791
2025
Q2 		$1.33K Hold
16
– – ﹤0.01% 803
2025
Q1 		$1.3K Hold
16
– – ﹤0.01% 808
2024
Q4 		$1.44K Hold
16
– – ﹤0.01% 832
2024
Q3 		$1.58K Hold
16
– – ﹤0.01% 804
2024
Q2 		$1.48K Hold
16
– – ﹤0.01% 892
2024
Q1 		$1.5K Buy
+16
New +$1.49K ﹤0.01% 889

Other funds holding XBI

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
AAS
Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return
WAM
Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return
RFM
Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return
NHFG
New Harbor Financial Group Worcester, Massachusetts $633M AUM 37.53% 1-Year Est. Return
MFS
Madrona Financial Services Everett, Washington $543M AUM 30.87% 1-Year Est. Return
LRPA
L. Roy Papp & Associates Phoenix, Arizona $951M AUM 29.05% 1-Year Est. Return
SGH
Sivik Global Healthcare Greenwich, Connecticut $132M AUM 24.1% 1-Year Est. Return
EWM
Edge Wealth Management New York $594M AUM 24.92% 1-Year Est. Return

Central Pacific Bank - Trust Division's XBI Position: Q2 2026 in Review

Central Pacific Bank - Trust Division increased its State Street SPDR S&P Biotech ETF (XBI) stake by 11% in Q2 2026, buying an estimated $406 and bringing the position to 30 shares worth $4.75K. The position accounts for ﹤0.01% of the portfolio, ranked #749.

Central Pacific Bank - Trust Division first reported a position in XBI in Q1 2024 and has held it in 10 quarters since. 234 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Central Pacific Bank - Trust Division held 30 shares of State Street SPDR S&P Biotech ETF worth $4.75K as of Q2 2026.
  • Central Pacific Bank - Trust Division bought 3 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $406.
  • State Street SPDR S&P Biotech ETF made up ﹤0.01% of Central Pacific Bank - Trust Division's portfolio in Q2 2026, its #749 holding.
  • Central Pacific Bank - Trust Division first reported a position in State Street SPDR S&P Biotech ETF in Q1 2024 and has held it in 10 quarters since.
  • 234 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Central Pacific Bank - Trust Division's 13F filing for Q2 2026, filed 7 Jul 2026.